Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your just spreading fud .
We'll soon see. Going to be interesting
No change on E-trade platform, 4.95 per trade as usual to sell. New platform notice- "By placing this order, you attest that you are not an Affiliate, Insider, or Control Person of the issuer and that the order is self-directed and unsolicited."
Going to be an interesting day. Is what it is since Leo still hasn't filed. Buying may be limited but don't know.
Posting history say's it all. Bash and trash right out the gate. Something I always check
My half penny's are a beautiful thing.
Why don't you? I already know.
This article has Dr Barrie Pittcock and A-273 together in the same story so clearly Dr Pittcock is taking A-273.
https://www.abc.net.au/news/2018-09-25/alzheimers-disease-research-questions-plaque-as-cause-of-disease/10299514
But still yet we have these Green days with a gaggle of close followers with ready made negativity ready to pounce
Owen: Train don't run out of Wichita... unlessin' you're a hog or a cattle.
Planes, Trains & Automobiles. Funny stuff
Not likely as IPIX has other staff. Better for Leo just to keep reporting among other legal matters. He can't just hide from it.
The company didn't report the BeaMed 510k laser fibers approval from last Dec 6 either. Not filing an easy quarterly report is strange. Could be there is something they are keeping a lid on. Who knows but like you say Leo could make this all go away by just filing.
Replay of today's conference- https://wsw.com/webcast/needham138/avxl/2276794
Posted in Anavex investor material
This is April fools day
Hey skitahoe you can find outstanding shares material on the yahoo financial pages. Last report said Shares Outstanding 82.11M.
https://finance.yahoo.com/quote/AVXL/key-statistics
At least it bounced off the bottom
It said the person you are trying to reach is not excepting calls at this time.
Your up late again.
Feb 7 Missling said " Regarding the EMA submission, we said that we like to do this as soon as possible in 2024 and that’s exactly what we’re doing. So we are really very active on preparing every module and to submit it.
So even now it's likely the submission hasn't taken place just yet. If submitted in May we could be looking at 2025 summer time frame before we get an answer. We would likely get FDA accelerated approval much sooner. Also the peer review.
Whew they drove this hard today. No reason for it so I kept buying.
If one bought 500,000 at half a penny looking back ain't bad.
True, but I know some of the posters here are SAVA investors and there's one thing you don't see is reams of negative posts on that board even though there have been (missteps).
Your shorts are showing..
Yep we are in a waiting period. Agree dilution not happening. Kips holding.
I see someone cut the bid. Thanks!
Thanks, but that was a non-answer. I see for some reason you didn't reference this filing
SML is now BeaMed (as reported in press release) which IPIX owns 41.6% equity securities fully diluted.
From the June 2022 8-K-
On June 9, 2022, Innovation Pharmaceuticals Inc. (the “Company”) entered into a Series A Preferred Share Purchase Agreement (the “Purchase Agreement”) with Squalus Med Ltd., a company established under the laws of the State of Israel (“SML”), pursuant to which the Company purchased 55,556 shares of SML’s Series A Redeemable Preferred Shares (the “Series A Shares”) and a warrant (the “Warrant”) to purchase 27,778 Series A Shares for aggregate consideration of $4,000,000, or approximately $72.00 per Series A Share. Following the closing under the Purchase Agreement, the Company owns approximately 35.7% of SML’s issued and outstanding equity securities and approximately 41.6% of SML’s equity securities on a fully diluted basis. The Company also entered into customary investor rights and indemnification agreements with SML.
https://www.sec.gov/Archives/edgar/data/1355250/000147793222004401/ipix_8k.htm
How much total ownership do you say?
Green!
Don't blink
Excellent. So new and improved fiber technology for hard to treat malady's using their StingRay systems.
Device Description: Page 2 of 4.
The BeaMed Laser Surgery Fibers are sterile, single use, laser delivery devices intended for
medical applications in various fields of laser surgery. They are intended to deliver energy to
soft tissue in contact and non-contact mode during various surgical applications, including via
endoscopes and cytoscopes. The fibers are designed to transmit energy from the laser system
to the treatment site, as well as to transmit a low power laser aiming beam to assist in the
visibilty of the target tissue.
Indications for Use:
The Fibers are indicated for use in general surgical applications for incision, excision,
vaporization, ablation, hemostasis or coagulation of soft tissue. It is also indicated for use in
open or closed endoscopic applications where incision, excision, tissue dissection, excision of
external tumors and lesions, complete or partial resection of internal organs, tumors or lesions,
tissue vaporization, hemostasis and or coagulation may be indicated.
The BeaMed Laser Surgery Fibers have a wavelength range of 450 nm to 2100 nm, can be
used in contact and non-contact mode and are indicated for use in general surgery, urology,
gastroenterology, gynecology, dermatology, vascular surgery, neurosurgery, plastic surgery,
ENT and endovenous occlusion of the greater saphenous vein in the patient with superficial
vein reflux and laser assisted lipolysis with a cleared compatible laser marketed for the
mentioned intended uses and using an SMA 905 connector.
https://www.accessdata.fda.gov/cdrh_docs/pdf23/K232769.pdf
Bump " A successful Squalus 510k could result in our shares appreciating substantially."
85% chance of EMA approval vs 0% for Mabs.
I like our chances- "Significant slowing in the rate of pathological brain atrophy"
Data Safety Monitoring Board (DSMD) reported Brilacidin is safe. A poster who denies Bril's safety is a tool.
You just pumped Lilly bashed AVXL and then thanked us for it. Nice going.
Another fresh print, good to see- "We studied brilacidin, an arylamide of this type, for its activity in vitro against fungi (40 clinical isolates, 20 species) that the World Health Organization has highlighted as problem human pathogens. We find antifungal activity at low concentrations for many pathogens, which indicates further screening for activity, particularly in vivo, is justified to evaluate this compound, and other mimetics, as attractive leads for development of effective antifungal agents".
Looks like further funding. Nice find Frenchbroad
Yes hope springs eternal around here:)
Strange IPIX has not sent out a press release on any matters since August. So six months of Leo drawing a salary with nothing to show for it or is there something in the works.
There is a limited and not very effective number of drugs available to combat the disease. So good to see Brilacidin being effective and still funded. Looking for B to be licensed and becoming part of this treatment arsenal. We'll see.
New Brilacidin report- https://figshare.com/articles/journal_contribution/Brilacidin_a_novel_antifungal_agent_against_i_Cryptococcus_neoformans_i_/25239550
"Our results indicate that BRI is a novel antifungal drug against cryptococcosis."